RION
RION is a clinical-stage regenerative medicine company based in Rochester, MN, focused on revolutionizing exosome science to heal from within. Established in 2017, RION leverages the unique properties of exosomes derived from platelets to develop innovative therapies aimed at enhancing tissue regeneration and addressing various medical challenges.
Industries
Nr. of Employees
small (1-50)
Awards
Fiscal Year 2024 Military Prototype Advancement Initiative (MPAI)
Platelet-Derived Extracellular Vesicles for the Treatment of Achilles Tendinopathy (Clinical Trial)
Funding (ceiling)
$2,576,446.7
Award Year
2024
Patents
Particle measuring device, calibration method, and measuring device
2023-10-03 • US-11774340-B2
View DetailsMicrobial particle measuring apparatus and microbial particle measuring method
2022-10-18 • US-11474017-B2
View Details
Particle measuring device, calibration method, and measuring device
2023-10-03 • US-11774340-B2
View DetailsMicrobial particle measuring apparatus and microbial particle measuring method
2022-10-18 • US-11474017-B2
View DetailsProducts
Purified platelet-derived exosome product (lyophilized exosome drug substance)
A lyophilized drug-substance composed of platelet-derived extracellular vesicles formulated for reconstitution; vials can be manufactured to contain up to multi-trillion vesicle doses and are stated to be stable at room temperature for 24 months.
Purified platelet-derived exosome product (lyophilized exosome drug substance)
A lyophilized drug-substance composed of platelet-derived extracellular vesicles formulated for reconstitution; vials can be manufactured to contain up to multi-trillion vesicle doses and are stated to be stable at room temperature for 24 months.
Expertise Areas
- Exosome manufacturing and scale-up
- Exosome-based drug delivery
- Regenerative medicine preclinical development
- Early-phase clinical trial management
Key Technologies
- Extracellular vesicle/exosome isolation
- Lyophilization (freeze-drying) for biologics
- Nanoparticle tracking analysis (NTA)
- Transmission electron microscopy (TEM)
Key People
Co-Founder
Co-Founder
Chief Financial Officer
Chief Regulatory Officer
Chief Administrative Officer
Chief Technical Operations
Co-Founder
Co-Founder
Chief Financial Officer
Chief Regulatory Officer
Chief Administrative Officer
Chief Technical Operations
News & Updates
RION received recognition for its innovative contributions to the field of regenerative medicine.
RION has strengthened its leadership team by appointing five experts to its advisory boards.
RION has begun a clinical study to assess the effectiveness of PEP™ in treating knee osteoarthritis.
The company has successfully dosed its first patient in a clinical study targeting diabetic foot ulcers with PEP™.
RION has announced the expansion of its manufacturing capabilities with a new facility in Rochester.
RION received recognition for its innovative contributions to the field of regenerative medicine.
RION has strengthened its leadership team by appointing five experts to its advisory boards.
RION has begun a clinical study to assess the effectiveness of PEP™ in treating knee osteoarthritis.
The company has successfully dosed its first patient in a clinical study targeting diabetic foot ulcers with PEP™.
RION has announced the expansion of its manufacturing capabilities with a new facility in Rochester.